Cmed Technology Invited to Participate at World TB Day
Cmed Technology, an eClinical technology provider, announced today it has been invited to participate at the annual World TB Day, which is being held tomorrow at Washington, D.C.’s U.S. Capitol Visitor Center. Throughout the day, Cmed Technology will conduct live demonstrations of its latest on-demand eClinical platform, Timaeus 5, using an Apple iPad®.
Tomorrow’s Senate briefing discusses the current state of tuberculosis (TB) and drug-resistant TB strains. Tuberculosis is a global problem; one of 10 people infected will develop the active form of the disease during their lifetime, according to the World Health Organization (WHO). The Bacille Calmette Guerin (BCG) vaccine, which is currently the only available vaccine against tuberculosis, provides limited protection against pulmonary tuberculosis and is not effective in adults. There is currently no licensed vaccine in the United States.
Cmed Technology’s Timaeus, which manages clinical data from Study Design through Reporting, has been supporting large-scale TB trials in difficult and remote geographies since 2008. In many countries, especially developing countries, trial sites may be situated in remote locations where Internet connectivity is unstable or not available at all. Because Timaeus allows clinicians to maintain full data communication using only mobile and/or low-speed connections without loss of performance, clinical trial sites can electronically capture data on-demand, allowing the data to be managed and reviewed in real time regardless of a site’s location.
“Cmed Technology Group feels honored to have been asked to participate at World TB Day because of our Timaeus eClinical platform being used to capture, manage and report clinical trial data in remote geographies with challenging circumstances,” said James Haughwout, Cmed Technology’s Vice President of Commercialization and Operations. “By giving trial sites the means to not being tethered to fixed, high-speed Internet connections, Cmed Technology is letting physicians bring innovation to wherever patients are located. Our hope is that Timaeus will help speed up the development of TB vaccines and treatments.”
What: World TB Day, demonstration of Timaeus 5 using an Apple iPad®
Where: U.S. Capitol Visitor Center, Rooms 210-212, Washington, D.C.
When
: March 24, 2011 (Thursday), 11 a.m.-2 p.m.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
